Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Adrian Pelin, Stephen Boulton, Levi A. Tamming, John C. Bell & Ragunath Singaravelu. (2020) Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity. Expert Opinion on Biological Therapy 20:9, pages 1083-1097.
Read now
Read now
Articles from other publishers (46)
Behnaz Taheri, Zeinab Zarei-Behjani, Abouzar Babaei & Fatemeh Matin Moradkhan. (2023) Extracellular Vesicles: a Trojan Horse Delivery Method for Systemic Administration of Oncolytic Viruses. Regenerative Engineering and Translational Medicine 9:4, pages 447-457.
Crossref
Crossref
Tedi Ramaj & Xingfu Zou. (2023) On the treatment of melanoma: A mathematical model of oncolytic virotherapy. Mathematical Biosciences 365, pages 109073.
Crossref
Crossref
Andrea Vannini, Federico Parenti, Catia Barboni, Cristina Forghieri, Valerio Leoni, Mara Sanapo, Daniela Bressanin, Anna Zaghini, Gabriella Campadelli-Fiume & Tatiana Gianni. (2023) Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice. Cancers 15:16, pages 4042.
Crossref
Crossref
Palaniyandi Muthukutty & So Young Yoo. (2023) Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective. Viruses 15:8, pages 1645.
Crossref
Crossref
Shijie Duan, Shuhang Wang, Lei Qiao, Xinbo Yu, Nan Wang, Liting Chen, Xinyuan Zhang, Xu Zhao, Hongyu Liu, Tianye Wang, Ying Wu, Ning Li & Funan Liu. (2023) Oncolytic Virus‐Driven Biotherapies from Bench to Bedside. Small 19:23.
Crossref
Crossref
Miranda Sam, Mohammed Selman, Weilong Zhao, Jiwon Jung, Aarron Willingham, Uyen Phan, Gary C. Starling & Qinshan Gao. (2023) Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome. Journal of Virology 97:5.
Crossref
Crossref
Weiyue Ban, Mengchi Sun, Hanwei Huang, Wanxu Huang, Siwei Pan, Pengfei Liu, Bingwu Li, Zhenguo Cheng, Zhonggui He, Funan Liu & Jin Sun. (2023) Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy. Nature Communications 14:1.
Crossref
Crossref
Mobarakeh Ajam-Hosseini, Fatemeh Akhoondi & Mohammad Doroudian. (2023) Nano based-oncolytic viruses for cancer therapy. Critical Reviews in Oncology/Hematology 185, pages 103980.
Crossref
Crossref
Alvaro Morales-Molina, Miguel Ángel Rodriguez-Milla, Stefano Gambera, Teresa Cejalvo, Belén de Andrés, María-Luisa Gaspar & Javier García-Castro. (2023) Toll-like Receptor Signaling–deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing. Cancer Research Communications 3:3, pages 347-360.
Crossref
Crossref
Brock D. Sherlock & Adelle C.F. Coster. (2023) Oncolytic virus treatment of human breast cancer cells: Modelling therapy efficacy. Journal of Theoretical Biology 560, pages 111394.
Crossref
Crossref
Jyoti Malhotra & Edward S. Kim. (2022) Oncolytic Viruses and Cancer Immunotherapy. Current Oncology Reports 25:1, pages 19-28.
Crossref
Crossref
Victor Naumenko, Jahanara Rajwani, Madison Turk, Chunfen Zhang, Mandy Tse, Rachelle P. Davis, Daesun Kim, Andrea Rakic, Himika Dastidar, Shinia Van, Laura K. Mah, Esha K. Kaul, Vladimir P. Chekhonin, Douglas J. Mahoney & Craig N. Jenne. (2022) Repeated dosing improves oncolytic rhabdovirus therapy in mice via interactions with intravascular monocytes. Communications Biology 5:1.
Crossref
Crossref
Mahdie Jafari, Maryam Kadkhodazadeh, Mina Bahrololoumi Shapourabadi, Nasser Hashemi Goradel, Mohammad Ali Shokrgozar, Arash Arashkia, Shahriyar Abdoli & Zahra Sharifzadeh. (2022) Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses. Frontiers in Immunology 13.
Crossref
Crossref
Annette Runge, Monika Petersson & Herbert Riechelmann. (2022) Onkolytische Virotherapie bei Kopf-Hals-Karzinomen. Laryngo-Rhino-Otologie 101:10, pages 787-796.
Crossref
Crossref
Qing Ji, Yuchen Wu, Andreas Albers, Meiyu Fang & Xu Qian. (2022) Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches. Pharmaceutics 14:9, pages 1811.
Crossref
Crossref
Mohsen Keshavarz, Seyed Mohammad Miri, Emad Behboudi, Yaser Arjeini, Hassan Dianat-Moghadam & Amir Ghaemi. (2022) Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives. International Immunopharmacology 108, pages 108882.
Crossref
Crossref
Christine E. Engeland, Johannes P.W. Heidbuechel, Robyn P. Araujo & Adrianne L. Jenner. (2022) Improving immunovirotherapies: the intersection of mathematical modelling and experiments. ImmunoInformatics 6, pages 100011.
Crossref
Crossref
Congwen Li, Jiawen Qian & Yiwei Chu. (2022) Advances in Brain Delivery Systems Based on Biomimetic Nanoparticles. ChemNanoMat 8:6.
Crossref
Crossref
Weiyue Ban, Jianhuan Guan, Hanwei Huang, Zhonggui He, Mengchi Sun, Funan Liu & Jin Sun. (2022) Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy. Nano Research 15:5, pages 4137-4153.
Crossref
Crossref
John D. Christie, Nicole Appel, Liqiang Zhang, Kenneth Lowe, Jacquelyn Kilbourne, Juliane Daggett-Vondras, Natalie Elliott, Alexandra R. Lucas, Joseph N. Blattman, Masmudur M. Rahman & Grant McFadden. (2022) Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma. Cancers 14:2, pages 337.
Crossref
Crossref
Faith Hannah Nutter Howard, Alessandra Iscaro & Munitta Muthana. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies
211
230
.
Ilse Hernandez-Aguirre & Kevin A. Cassady. 2022. Cancer Immunology and Immunotherapy. Cancer Immunology and Immunotherapy
375
437
.
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Federico Banchelli, Roberto D’Amico, Massimo Dominici & Khawaja Husnain Haider. 2022. Handbook of Stem Cell Therapy. Handbook of Stem Cell Therapy
1303
1331
.
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Federico Banchelli, Roberto D’Amico, Massimo Dominici & Khawaja Husnain Haider. 2022. Handbook of Stem Cell Therapy. Handbook of Stem Cell Therapy
1
29
.
Li Ding, Qingqing Gao, Zhuobin Xu, Liangliang Cai, Sujuan Chen, Xinyue Zhang, Peng Cao & Gang Chen. (2021) An Inter‐Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer. Advanced Science 9:2.
Crossref
Crossref
Johannes P. W. Heidbuechel & Christine E. Engeland. (2021) Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Yalei Zhang, Ye Li, Kun Chen, Ling Qian & Peng Wang. (2021) Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy. Cancer Cell International 21:1.
Crossref
Crossref
Rui He, Yefang Lao, Wenyan Yu, Xiaohui Zhang, Min Jiang & Chunrong Zhu. (2021) Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Juan Fueyo, Candelaria Gomez-Manzano, Frederick F Lang & Marta M Alonso. (2021) Hitchhiking to brain tumours: stem cell delivery of oncolytic viruses. The Lancet Oncology 22:8, pages 1049-1051.
Crossref
Crossref
José Rico, Claudia Perez, Juan Hernandez, Carlos Guerrero & Orlando Acosta. (2021) Cell surface heat shock protein-mediated entry of tumor cell-adapted rotavirus into U-937 cells. Folia Microbiologica 66:4, pages 623-638.
Crossref
Crossref
Chen Yang, Nanni Hua, Shufang Xie, Yi Wu, Lifeng Zhu, Shibing Wang & Xiangmin Tong. (2021) Oncolytic viruses as a promising therapeutic strategy for hematological malignancies. Biomedicine & Pharmacotherapy 139, pages 111573.
Crossref
Crossref
Alexander Malogolovkin, Nizami Gasanov, Alexander Egorov, Marianna Weener, Roman Ivanov & Alexander Karabelsky. (2021) Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes. Viruses 13:7, pages 1271.
Crossref
Crossref
Elizaveta Sergeevna Podshivalova, Alevtina Sergeevna Semkina, Dmitry Sergeevich Kravchenko, Elena Ivanovna Frolova & Stepan Petrovich Chumakov. (2021) Efficient delivery of oncolytic enterovirus by carrier cell line NK-92. Molecular Therapy - Oncolytics 21, pages 110-118.
Crossref
Crossref
Claudia Hill, Megan Grundy, Luca Bau, Sheena Wallington, Joel Balkaran, Victor Ramos, Kerry Fisher, Len Seymour, Constantin Coussios & Robert Carlisle. (2021) Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus. Molecular Therapy - Oncolytics 21, pages 47-61.
Crossref
Crossref
James A. Davies, Gareth Marlow, Hanni K. Uusi-Kerttula, Gillian Seaton, Luke Piggott, Luned M. Badder, Richard W. E. Clarkson, John D. Chester & Alan L. Parker. (2021) Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20. Viruses 13:5, pages 864.
Crossref
Crossref
Dong Ho Shin, Teresa Nguyen, Bulent Ozpolat, Frederick Lang, Marta Alonso, Candelaria Gomez-Manzano & Juan Fueyo. (2021) Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy. Journal for ImmunoTherapy of Cancer 9:4, pages e002086.
Crossref
Crossref
Yu Tang & Yanguang Cao. (2021) Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions. Pharmaceutics 13:3, pages 422.
Crossref
Crossref
Kaitlin M Dailey, JuliAnne E Allgood, Paige R Johnson, Mackenzie A Ostlie, Kambri C Schaner, Benjamin D Brooks & Amanda E Brooks. (2021) The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering. Future Microbiology 16:5, pages 341-368.
Crossref
Crossref
Dileep D. Monie, Archis R. BhandarkarIan F. ParneyCristina CorreiaJann N. Sarkaria, Richard G. VileHu Li. (2021) Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma. Neurosurgical Focus 50:2, pages E10.
Crossref
Crossref
Rafael Moreno. (2021) Mesenchymal stem cells and oncolytic viruses: joining forces against cancer. Journal for ImmunoTherapy of Cancer 9:2, pages e001684.
Crossref
Crossref
Joselle Cook, Aldo A. Acosta-Medina, Kah Whye Peng, Martha Lacy & Stephen Russell. (2021) Oncolytic virotherapy – Forging its place in the immunomodulatory paradigm for Multiple Myeloma. Cancer Treatment and Research Communications 29, pages 100473.
Crossref
Crossref
Coraline Chéneau & Eric J. Kremer. (2020) Adenovirus—Extracellular Protein Interactions and Their Impact on Innate Immune Responses by Human Mononuclear Phagocytes. Viruses 12:12, pages 1351.
Crossref
Crossref
Chang-Myung Oh, Hong Jae Chon & Chan Kim. (2020) Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors. International Journal of Molecular Sciences 21:20, pages 7743.
Crossref
Crossref
Mary Cook & Aman Chauhan. (2020) Clinical Application of Oncolytic Viruses: A Systematic Review. International Journal of Molecular Sciences 21:20, pages 7505.
Crossref
Crossref
Wen Lei, Shibing Wang, Nengwen Xu, Yu Chen, Gongqiang Wu, Aibin Zhang, Xiaomin Chen, Yin Tong & Wenbin Qian. (2020) Enhancing therapeutic efficacy of oncolytic vaccinia virus armed with Beclin-1, an autophagic Gene in leukemia and myeloma. Biomedicine & Pharmacotherapy 125, pages 110030.
Crossref
Crossref
Meijun Zheng, Jianhan Huang, Aiping Tong & Hui Yang. (2019) Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances. Molecular Therapy - Oncolytics 15, pages 234-247.
Crossref
Crossref